← Open Payments lookup

SISSY HINOJOS: Open Payments

NPI 1972843795 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,108 in 123 payments from 45 companies in 2025. Trend: 2023 $5,246 · 2024 $3,950 · 2025 $4,108

Food & beverage: $4,108
CompanyPaymentsAmount
Janssen Biotech, Inc.12$448
AstraZeneca Pharmaceuticals LP9$360
Genmab U.S., Inc.4$257
Pharmacosmos Therapeutics Inc.6$218
GlaxoSmithKline, LLC.7$209
Incyte Corporation4$177
Stemline Therapeutics Inc.4$156
Lilly USA, LLC4$151
Exelixis Inc.3$145
Myriad Genetic Laboratories, Inc.2$140

Products named: RYBREVANT, JEMPERLI, DARZALEX, MONOFERRIC, MONJUVI, Orserdu, VERZENIO, CABOMETYX.

Industry payments across TX — which companies pay providers there.